Leisure Acquisition (LACQ) Competitors

Leisure Acquisition (NASDAQ:LACQ) and Fortress Biotech (NASDAQ:FBIO) are both small-cap companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, media sentiment, valuation, risk, earnings, community ranking, dividends, analyst recommendations and institutional ownership.

Is LACQ or FBIO more profitable?

Leisure Acquisition has a net margin of 0.00% compared to Fortress Biotech's net margin of -84.53%. Leisure Acquisition's return on equity of 30.17% beat Fortress Biotech's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Leisure Acquisition	N/A	30.17%	6.14%
Fortress Biotech	-84.53%	N/A	-34.93%

Does the MarketBeat Community believe in LACQ or FBIO?

Fortress Biotech received 328 more outperform votes than Leisure Acquisition when rated by MarketBeat users.

Company	Underperform	Outperform
Leisure Acquisition	N/A	N/A
Fortress Biotech	Outperform Votes 328 63.69%	Underperform Votes 187 36.31%

Which has stronger earnings & valuation, LACQ or FBIO?

Leisure Acquisition has higher earnings, but lower revenue than Fortress Biotech.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Leisure Acquisition	N/A	N/A	$4.31M	N/A	N/A
Fortress Biotech	$57.78M	0.95	-$60.64M	-$2.23	-0.83

Does the media prefer LACQ or FBIO?

In the previous week, Fortress Biotech had 2 more articles in the media than Leisure Acquisition. MarketBeat recorded 2 mentions for Fortress Biotech and 0 mentions for Leisure Acquisition. Fortress Biotech's average media sentiment score of 0.94 beat Leisure Acquisition's score of -1.38 indicating that Fortress Biotech is being referred to more favorably in the news media.

Company	Overall Sentiment
Leisure Acquisition	Negative
Fortress Biotech	Positive

Do analysts recommend LACQ or FBIO?

Fortress Biotech has a consensus target price of $21.00, indicating a potential upside of 1,035.14%. Given Fortress Biotech's stronger consensus rating and higher probable upside, analysts clearly believe Fortress Biotech is more favorable than Leisure Acquisition.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Leisure Acquisition	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Fortress Biotech	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00

Do insiders and institutionals hold more shares of LACQ or FBIO?

56.7% of Leisure Acquisition shares are held by institutional investors. Comparatively, 96.5% of Fortress Biotech shares are held by institutional investors. 39.6% of Leisure Acquisition shares are held by insiders. Comparatively, 27.9% of Fortress Biotech shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Which has more volatility and risk, LACQ or FBIO?

Leisure Acquisition has a beta of -0.3, meaning that its stock price is 130% less volatile than the S&P 500. Comparatively, Fortress Biotech has a beta of 1.76, meaning that its stock price is 76% more volatile than the S&P 500.

Summary

Fortress Biotech beats Leisure Acquisition on 9 of the 14 factors compared between the two stocks.